Stomach cancer is a growth of abnormal tissues that form a tumor in the part of your abdomen. Symptoms of stomach cancer often include persistent abdominal pain, extreme heartburn, extreme vomiting, severe indigestion, abdominal swelling, and frequent diarrhea. These symptoms are common in all types of stomach cancer, but when cancer spreads to the upper chest, the symptoms become much more severe and can eventually cause death. Stomach cancer has the highest survival rate of any cancer in the world. Crocetin (trade name Eulexin) is the first gastric cancer drug used in the treatment of stomach cancer. It was later approved for the treatment of peritoneal mesothelioma, but was not widely marketed due to its negative initial results.
🎬📺 Free Movies and Free TV Shows! 🎭🎬
The increasing prevalence of gastric cancer is expected to drive the growth of the global gastric cancer drug market during the forecast period. According to the American Cancer Society (ACS), approximately 27,600 new cases of stomach cancer are expected to be diagnosed in the US by 2020. More than 1 million new cases of cancer were diagnosed worldwide in 2018, according to the World Cancer Research Fund. globe. Stomach cancer is the fourth most common cancer in men and the seventh most common cancer in women. As a result, the demand for gastric cancer drugs worldwide has increased significantly for adequate treatment options. Therefore, these factors are expected to drive the growth of the global gastric cancer drug market during the forecast period. In addition, the advent of new therapies for metastatic gastric cancer is expected to drive global gastric cancer drug market growth during the forecast period.
Request a sample copy of this report @
The main key players profiled in this report are: Bristol-Myers Squibb, GlaxoSmithKline PLC, Celltrion Inc., Pfizer Inc., Sanofi, Eli, Lily and Company, Merck, Novartis International AG, F. Hoffmann-La Roche Ltd. and Otsuka Holdings Co. Ltd.
In August 2020, Celltrion Inc. for example, the World Health Organization (WHO) prequalification standards for its biosimilar Herzuma, indicated for gastric and breast cancer.
Stomach Cancer Drugs Market Segmentation:
By therapy type:
- Kinase Inhibitors
- Nucleoside Metabolic Inhibitors
- Microtubule Inhibitors
- VEGF antibodies
- HER2 receptor antagonists
- Car T cell therapy
- Gastrointestinal Stromal Tumors
- Carcinoid Tumors
By distribution channel:
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Global Gastric Cancer Drugs Market: Regional Segments:
The various Regional Segmentation section represents the regional aspects of the global Stomach Cancer Drugs market. This chapter describes the regulatory structure that is likely to affect the entire market. It highlights the political landscape in the market and forecast its impact on the Gastric Cancer Drugs market worldwide.
North America (US, Canada)
Europe (Germany, UK, France, Rest of Europe)
Asia-Pacific (China, Japan, India, Rest of Asia Pacific)
Latin America (Brazil, Mexico)
Middle East and Africa
LIMITED TIME OFFER – Hurry!
Exclusive offer!!! Buy the report at a discounted rate!!!
Get discount for buyers UP TO 30% OFF on every research report
Buy this complete business report:
What can you expect from the report?
- Stomach Cancer Drugs Total Available Market (TAM) Size
- Stomach Cancer Drugs Serviceable Available Market (SAM) Size)
- Business implications of COVID-19 on the overall market
- Market share/revenue share (%) of top market players in total market size (2019)
- Market Size and Forecast (2020-2027) by Country and Regional Level, by Segment
- Overview and analysis of the key players in the market
The Stomach Cancer Drugs Industry focuses on major industry leading players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also performed. The Global Stomach Cancer Drugs market development trends and marketing channels are analyzed. Finally, the feasibility of new investment projects is assessed and general research conclusions are presented. With tables and figures available, the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
The study goals are:
- To analyze and research the global Stomach Cancer status and future forecast of production, revenue, consumption, historical data and forecast.
- To present the key Stomach Cancer Drugs manufacturers, production, revenue, market share and recent development.
- To split the Breakdown Data by Regions, Type, Manufacturer, and Application.
- To analyze the market potential and benefit, opportunities and challenges, constraints and risks of the global and key regions.
- To identify significant trends, drivers and influencing factors in the world and regions.
- To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
Request for PDF brochure @
The market information service of Coherent Market Insights provides a complete picture of the market, using existing information sources. Our market information service tackles the main challenges of a market; helps to find opportunities in different sectors and helps potential investors and partners to support the strategic decision-making process.
Industry analysis is a critical step in today’s competitive market that helps identify the right target customers and provide tailor-made solutions based on their business needs. Every aspect and unique challenge brought up by a particular industry is carefully considered when formulating these solutions. It also takes into account various government reforms, competitive environment, customer behavior, existing and future business models and ever-changing technological developments. Sector analysis helps an organization formulate strategies and policies of a company.
Senior Client Partner – Business Development